Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.
van Dongen JJ, Seriu T, Panzer-Grümayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig WD, Basso G, de Bruijn MA, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WC, Riehm H, Bartram CR. van Dongen JJ, et al. Among authors: de bruijn ma. Lancet. 1998 Nov 28;352(9142):1731-8. doi: 10.1016/S0140-6736(98)04058-6. Lancet. 1998. PMID: 9848348
Detection of minimal residual disease in acute leukemia patients.
van Dongen JJ, Szczepański T, de Bruijn MA, van den Beemd MW, de Bruin-Versteeg S, Wijkhuijs JM, Tibbe GJ, van Gastel-Mol EJ, Groeneveld K, Hooijkaas H. van Dongen JJ, et al. Among authors: de bruin versteeg s, de bruijn ma. Cytokines Mol Ther. 1996 Jun;2(2):121-33. Cytokines Mol Ther. 1996. PMID: 9384697 Review.
Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease.
Beishuizen A, de Bruijn MA, Pongers-Willemse MJ, Verhoeven MA, van Wering ER, Hählen K, Breit TM, de Bruin-Versteeg S, Hooijkaas H, van Dongen JJ. Beishuizen A, et al. Among authors: de bruin versteeg s, de bruijn ma. Leukemia. 1997 Dec;11(12):2200-7. doi: 10.1038/sj.leu.2400904. Leukemia. 1997. PMID: 9447841
Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease.
Szczepański T, Langerak AW, Wolvers-Tettero IL, Ossenkoppele GJ, Verhoef G, Stul M, Petersen EJ, de Bruijn MA, van't Veer MB, van Dongen JJ. Szczepański T, et al. Among authors: de bruijn ma. Leukemia. 1998 Jul;12(7):1081-8. doi: 10.1038/sj.leu.2401071. Leukemia. 1998. PMID: 9665194
Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease.
Szczepański T, Beishuizen A, Pongers-Willemse MJ, Hählen K, Van Wering ER, Wijkhuijs AJ, Tibbe GJ, De Bruijn MA, Van Dongen JJ. Szczepański T, et al. Among authors: de bruijn ma. Leukemia. 1999 Feb;13(2):196-205. doi: 10.1038/sj.leu.2401277. Leukemia. 1999. PMID: 10025893 Clinical Trial.
Predictive Value of Serum Neurofilament Light Chain Levels in Anti-NMDA Receptor Encephalitis.
Brenner J, Mariotto S, Bastiaansen AEM, Paunovic M, Ferrari S, Alberti D, de Bruijn MAAM, Crijnen YS, Schreurs MWJ, Neuteboom RF, Damoiseaux JGMC, de Vries JM, Titulaer MJ. Brenner J, et al. Among authors: de bruijn maam. Neurology. 2023 May 23;100(21):e2204-e2213. doi: 10.1212/WNL.0000000000207221. Epub 2023 Apr 4. Neurology. 2023. PMID: 37015822 Free PMC article.
Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy.
Bastiaansen AEM, de Bruijn MAAM, Schuller SL, Martinez-Hernandez E, Brenner J, Paunovic M, Crijnen YS, Mulder MJHL, Schreurs MWJ, de Graaff E, Smitt PAE, Neuteboom RF, de Vries JM, Titulaer MJ. Bastiaansen AEM, et al. Among authors: de bruijn maam. Neurol Neuroimmunol Neuroinflamm. 2021 Dec 22;9(2):e1127. doi: 10.1212/NXI.0000000000001127. Print 2022 Mar. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34937737 Free PMC article.
Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis.
de Bruijn MAAM, Aarsen FK, van Oosterhout MP, van der Knoop MM, Catsman-Berrevoets CE, Schreurs MWJ, Bastiaansen DEM, Sillevis Smitt PAE, Neuteboom RF, Titulaer MJ; CHANCE Study Group. de Bruijn MAAM, et al. Neurology. 2018 May 29;90(22):e1997-e2005. doi: 10.1212/WNL.0000000000005605. Epub 2018 Apr 27. Neurology. 2018. PMID: 29703768 Free PMC article.
Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment.
Muñoz-Lopetegi A, de Bruijn MAAM, Boukhrissi S, Bastiaansen AEM, Nagtzaam MMP, Hulsenboom ESP, Boon AJW, Neuteboom RF, de Vries JM, Sillevis Smitt PAE, Schreurs MWJ, Titulaer MJ. Muñoz-Lopetegi A, et al. Neurol Neuroimmunol Neuroinflamm. 2020 Mar 2;7(3):e696. doi: 10.1212/NXI.0000000000000696. Print 2020 May. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32123047 Free PMC article.
Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes.
Bastiaansen AEM, de Jongste AHC, de Bruijn MAAM, Crijnen YS, Schreurs MWJ, Verbeek MM, Dumoulin DW, Taal W, Titulaer MJ, Sillevis Smitt PAE. Bastiaansen AEM, et al. Among authors: de bruijn maam. Neurooncol Adv. 2021 Sep 28;3(1):vdab145. doi: 10.1093/noajnl/vdab145. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34693289 Free PMC article.
36 results